Status:
COMPLETED
Improvement on GMFCS Level of Patients With Cerebral Palsy Treated by Repeated Botulinum Toxin-A
Lead Sponsor:
Kocaeli University
Conditions:
Cerebral Palsy
Eligibility:
All Genders
2-18 years
Brief Summary
The aim of this retrospective, monocenter, observational study is to evaluate the changes in GMFCS levels of children with cerebral palsy (CP) who received repeated Botulinum Toxin-A (BoNT-A) injectio...
Detailed Description
It is generally agreed that children with CP reach their gross motor potential by the age of 3.5-5 and a child or young person over the age of 5 years will not improve their GMFCS level. BoNT-A is an ...
Eligibility Criteria
Inclusion
- All children with a diagnosis of cerebral palsy with respect to Rosenbaum criteria
- Children who received at least 2 repeated BoNT-A injections to lower limb(s) as well as an integrated treatment approach (an intensive therapy protocol consisted of a half day or entire day program in Kocaeli University Department of PMR and Izmit Rehabilitation Center) within the last 10 years
Exclusion
- Children who did not receive repeated injections
- Children who did not receive an intensive therapy protocol
Key Trial Info
Start Date :
November 20 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 9 2018
Estimated Enrollment :
503 Patients enrolled
Trial Details
Trial ID
NCT03344952
Start Date
November 20 2017
End Date
November 9 2018
Last Update
November 30 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kocaeli University
Kocaeli, Turkey (Türkiye), 41050